GlassScriptPhysician profile
Derek A Besing
NPI 1003903378
$3,421.54
in general payments reported to CMS, 2019-2025
15 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $492 · 2021: $216 · 2022: $348 · 2023: $390 · 2024: $532 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,750.04 | 2019-2025 | Puraply Wound Matrix, Puraply, Puraply Am |
| Abbvie INC. | $491.99 | 2022-2025 | Dalvance, Avycaz, Teflaro |
| Mimedx Group, INC. | $430.56 | 2024-2025 | |
| Integra Lifesciences Corporation | $266.01 | 2019-2020 | |
| Kci USA, INC. | $126.03 | 2019-2020 | |
| Bioventus LLC | $71.09 | 2022 | |
| Tactile Systems Technology INC | $64.79 | 2019 | |
| Smith+Nephew, INC. | $56.80 | 2020-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Averitas Pharma INC. | $50.52 | 2023 | Qutenza |
| Merck Sharp & Dohme LLC | $25.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.29 | 2025 | |
| Nevro Corp. | $18.67 | 2024 | Senza |
| Polynovo North America LLC | $15.36 | 2025 | Novosorb Btm |
| Hartmann USA, INC. | $14.71 | 2025 | Zetuvit Plus 10x10 P10 |
| Aroa Biosurgery Incorporated | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Besing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.